Medical Marijuana ProCon.org HOME | CLOSE

1. Name: Kirsten R. Müller-Vahl, M.D.  
2. Title: Assistant Professor of Neurology & Director of Tourette Syndrome Clinic, Department of Clinical Psychiatry, Medical School of Hannover, Germany
3. Medical Marijuana
Position:
Pro to the question "Should marijuana be a medical option?"
4. Reasoning:

"There is anecdotal evidence to suggest that the consumption of marijuana clearly and continuously benefits Tourette patients. There is also a strong suggestion that the plant cannabis is more effective than synthetic THC, and that patients taking the mixture experience fewer unpleasant side effects."
April, 2002, "Marijuana Chemical Eases Tourette's Symptoms," Reuters Health by Hannah Cleaver

5. Credibility
Ranking:

 Key Experts
Physicians [We believe physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.]

6. Involvement:
  • Present, Director of Tourette Syndrome Clinic, Medical School of Hannover, Germany
  • Present, Assistant Professor of Neurology, Department of Clinical Psychiatry, Medical School of Hannover, Germany
  • 2005, Co-Presenter, "I-124-AM281 PET Imaging of CB1-Receptors in Schizophrenia: A Case Study," Poster Presentation, 2005 Conference on Cannabinoids
  • 2005, Member of Program Committee, 2001 Congress on Cannabis and the Cannabinoids
  • 2001, Workshop Leader, "Cannabinoids in the Treatment of Tourette Syndrome," 2001 Congress on Cannabis and the Cannabinoids
  • 2001, Member of Program Committee, 2001 Congress on Cannabis and the Cannabinoids
7. Education:
  • M.D., school unknown
8. Relevant Affiliations/Honors:
  • None found

9. Contact Info:
Phone: 0049 511 5323110 Fax: 0049 511 5323115
E-Mail:  mueller-vahl.kirsten@mh-hannover.de
Web Site: None listed

10. Other: Some of her recent publications include:
  • "Cannabinoids Reduce Symptoms of Tourette's Syndrome," Expert Opinion on Pharmacology, Vol. 4, No. 10, Pages 1717-1725, October, 2003
  • "Delta-9-Tetrahydrocannabinol )THC) is Effective in the Treatment of Tics in Tourette Syndrome: a 6-Week Randomized Trial," Journal of Clinical Psychiatry, April, 2003
  • "Combined Treatment of Tourette Syndrome with Delta-9-THC and Dopamine Receptor Antagonists," (with Udo Schneider, Hinderk M. Emrich), Journal of Cannabis Therapeutics, Vol. 2, No. 3-4, 2001
HOME | CLOSE